Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
ASCO Guidelines
00:00
Updated Guidelines for Adjuvant Abemaciclib in High-Risk Early Breast Cancer
This chapter covers updated recommendations for using adjuvant abemaciclib in high-risk early breast cancer patients, informed by findings from the Monarch E trial. It highlights the alignment with FDA indications and expands the treatment criteria for identifying eligible patients.
Play episode from 03:04
Transcript
